Plus Therapeutics
PSTV
PSTV was delisted on the 31st of July, 2026.
5 hedge funds and large institutions have $15.1M invested in Plus Therapeutics in 2015 Q2 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
217% more call options, than puts
Call options by funds: $19K | Put options by funds: $6K
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
67% more funds holding
Funds holding: 3 → 5 (+2)
22% less capital invested
Capital invested by funds: $19.3M → $15.1M (-$4.22M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$4.58M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$4.58M |
| 3 |
GC
Globeflex Capital
San Diego,
California
|
+$2.29M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$2.65M |
| 2 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
-$329K |
| 3 |
California State Teachers Retirement System (CalSTRS)
West Sacramento,
California
|
-$201K |
| 4 |
TA
Teachers Advisors
New York
|
-$170K |
| 5 |
RhumbLine Advisers
Boston,
Massachusetts
|
-$103K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TC
76
TFS Capital
West Chester,
Pennsylvania
| – | -$19K | – | – |
|
77
Two Sigma Investments
New York
| – | -$32K | – | – |
|
|
TSS
78
Two Sigma Securities
New York
| – | -$32K | – | – |
|
|
WA
79
Waverly Advisors
Birmingham,
Alabama
| – | -$3K | – | – |
|
PSTV Hedge Fund Activity: Q2 2015 in Review
5 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q2 2015, worth a combined $15.1M — down 22% from $19.3M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new PSTV positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $4.58M. The largest seller was BlackRock Fund Advisors, exiting entirely with an estimated $2.65M sold.
- 5 institutional investors held Plus Therapeutics (PSTV) as of Q2 2015, up from 3 in Q1 2015.
- Funds reported $15.1M of Plus Therapeutics stock for Q2 2015, down 22% quarter-over-quarter.
- 3 funds opened new Plus Therapeutics positions in Q2 2015 and 1 closed out, a net change of +2 holders.
- The largest Plus Therapeutics buyer in Q2 2015 was Sabby Management, an estimated $4.58M added.
- The largest Plus Therapeutics seller in Q2 2015 was BlackRock Fund Advisors, an estimated $2.65M sold.
Based on aggregated 13F filings for Q2 2015.